Cerebellar high-grade gliomas do not present the same molecular alterations as supratentorial high-grade gliomas and may show histone H3 gene mutations

被引:13
|
作者
Tauziede-Espariat, Arnault [1 ]
Saffroy, Raphael [2 ]
Pages, Melanie [1 ]
Pallud, Johan [3 ,4 ,5 ]
Legrand, Laurence [6 ]
Besnard, Aurore [1 ]
Lacombe, Joelle [1 ]
Lot, Guillaume [7 ]
Borha, Alin [8 ]
Tazi, Sanaa [9 ]
Adle-Biassette, Homa [10 ]
Polivka, Marc [10 ]
Lechapt, Emmanuele [1 ,11 ]
Varlet, Pascale [1 ]
机构
[1] St Anne Hosp, Dept Neuropathol, 1 Rue Cabanis, F-75014 Paris, France
[2] Hop Paul Brousse, Dept Biochem & Oncogenet, Villejuif, France
[3] St Anne Hosp, Dept Neurosurg, Paris, France
[4] Paris Descartes Univ, Sorbonne Paris Cite, Paris, France
[5] Ctr Psychiatrie & Neurosci, IMA Brain, INSERM, U894, Paris, France
[6] St Anne Hosp, Dept Radiol, Paris, France
[7] Rothschild Fdn, Dept Neurosurg, Paris, France
[8] Cote Nacre Hosp, Dept Neurosurg, Caen, France
[9] Mondor Hosp, Dept Neurosurg, Creteil, France
[10] Lariboisiere Hosp, AP HP, Dept Pathol, Paris, France
[11] Cote Nacre Hosp, Dept Pathol, Caen, France
关键词
glioblastoma; cerebellum; histones; REPAIR DEFICIENCY SYNDROME; GLIOBLASTOMA-MULTIFORME; K27M MUTATIONS; TUMORS; H3F3A; SUBGROUPS; LYMPHOMA; ATRX; P16;
D O I
10.5414/NP301104
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Numerous molecular alterations have been described in supratentorial high-grade gliomas (1p19q co-deletion, IDHI/2, histone H3, hTERT promotor mutations, loss of ATRX) which have led to a new histomolecular classification of diffuse gliomas. We aimed at describing these alterations in a series of 19 adults with pure cerebellar high-grade gliomas. Systematic immunohistochemical analyses, including that of IDHIR132H, ATRX, p53, PTEN, EGFR, p16, FGFR3, BRAFV600E, mismatch repair proteins, H3K27me3, H3K36me3. and H3K27M; molecular analyses of IDH1/2. hTERT, BRAF, H3F3A, and HIST1H3B mutation hotspots: and EGFR, PTEN FISH were retrospectively performed in a multicentric study. We histopathologically identified 14 glioblastomas, 4 grade III astrocytomas and 1 gliosarcoma. Two cases showed a H3F3A K27M mutation. Only one case harbored a classical profile of glioblastoma with hTERT mutation, EGFR gain and 10q loss. The most frequent alteration was the absence of p16 immunoexpression We report a histomolecular analysis of pure cerebellar high grade gliomas. The histomolecular profile appears to be different from that of supratentorial gliomas, with no IDH1/2 gene mutations and only 1 case with a classic profile of de novo glioblastoma. In 2 cases, we identified H3F3A K27M mutation, classically described in pediatric midline gliomas.
引用
收藏
页码:209 / 216
页数:8
相关论文
共 50 条
  • [31] Intracavitary radioimmunotherapy of high-grade gliomas: present status and future developments
    Reulen, Hans-Juergen
    Molina, Eric Suero
    Zeidler, Reinhard
    Gildehaus, Franz Josef
    Boening, Guido
    Gosewisch, Astrid
    Stummer, Walter
    ACTA NEUROCHIRURGICA, 2019, 161 (06) : 1109 - 1124
  • [32] Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future
    Ricky Chen
    Adam L. Cohen
    Howard Colman
    Current Treatment Options in Oncology, 2016, 17
  • [33] Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future
    Chen, Ricky
    Cohen, Adam L.
    Colman, Howard
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (08)
  • [34] Intracavitary radioimmunotherapy of high-grade gliomas: present status and future developments
    Hans-Jürgen Reulen
    Eric Suero Molina
    Reinhard Zeidler
    Franz Josef Gildehaus
    Guido Böning
    Astrid Gosewisch
    Walter Stummer
    Acta Neurochirurgica, 2019, 161 : 1109 - 1124
  • [35] Management of high-grade gliomas in the pediatric patient: Past, present, and future
    Vanan, Magimairajan Issai
    Eisenstat, David D.
    NEURO-ONCOLOGY PRACTICE, 2014, 1 (04) : 145 - 157
  • [36] Early initiation of chemoradiation may not influence survival of high-grade gliomas
    Maia Loureiro, Luiz Victor
    Fleury Malheiros, Suzana Maria
    JOURNAL OF NEURO-ONCOLOGY, 2018, 136 (01) : 215 - 216
  • [37] Early initiation of chemoradiation may not influence survival of high-grade gliomas
    Luiz Victor Maia Loureiro
    Suzana Maria Fleury Malheiros
    Journal of Neuro-Oncology, 2018, 136 : 215 - 216
  • [38] THE IDENTIFICATION AND VALIDATION OF PLASMA MEMBRANE PROTEINS AS POTENTIAL THERAPEUTIC TARGETS FOR HISTONE H3 MUTANT PAEDIATRIC HIGH-GRADE GLIOMAS
    Snary, Anya
    Haque, Farhana
    Pickering, James
    Rahman, Ruman
    Grundy, Richard
    Layfield, Robert
    NEURO-ONCOLOGY, 2022, 24 : 10 - 10
  • [39] THE IDENTIFICATION AND VALIDATION OF PLASMA MEMBRANE PROTEINS AS POTENTIAL THERAPEUTIC TARGETS FOR HISTONE H3 MUTANT PAEDIATRIC HIGH-GRADE GLIOMAS
    Snary, Anya
    Pickering, James
    Rahman, Ruman
    Grundy, Richard
    Haque, Farhana
    Layfield, Robert
    NEURO-ONCOLOGY, 2022, 24 : 173 - 174
  • [40] TREATMENT OF SUPRATENTORIAL HIGH-GRADE GLIOMAS WITH SPLIT COURSE HIGH FRACTIONAL DOSE POSTOPERATIVE RADIOTHERAPY
    MARCIALVEGA, VA
    WHARAM, MD
    LEIBEL, S
    CLARK, A
    ZWEIG, R
    ORDER, SE
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 16 (06): : 1419 - 1424